Hypoparathyroidism: is it that easy to treat?
Calcium
Hypoparathyroidism
PTH1-34
PTH1-84
Journal
Hormones (Athens, Greece)
ISSN: 2520-8721
Titre abrégé: Hormones (Athens)
Pays: Switzerland
ID NLM: 101142469
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
23
02
2018
accepted:
04
05
2018
pubmed:
8
6
2018
medline:
28
7
2019
entrez:
8
6
2018
Statut:
ppublish
Résumé
Hypoparathyroidism is a relatively rare endocrine disease characterised by either null or inappropriately low secretion of parathyroid hormone (PTH) for serum calcium levels. The other main laboratory findings include hypocalcaemia, inappropriately normal or high urine calcium excretion and hyperphosphataemia with low urine phosphate excretion. The management of hypoparathyroidism should be tailored to each individual case, which makes it a demanding undertaking in everyday clinical practice. In this review, we sought to focus on the diagnostic approach of hypoparathyroidism and the therapeutic challenges of the disease from a clinical perspective. Conventional treatment with vitamin D analogues and calcium salts is no longer the only available treatment, since replacement treatment with PTH(1-84) has recently been approved for the disease. However, the optimal treatment schedule is yet to be defined.
Identifiants
pubmed: 29876797
doi: 10.1007/s42000-018-0032-6
pii: 10.1007/s42000-018-0032-6
doi:
Substances chimiques
Parathyroid Hormone
0
Types de publication
Journal Article
Review
Langues
eng